Short-Term Glycemic Effects of Liquid Metformin vs Standard Tablets
Status:
NOT_YET_RECRUITING
Trial end date:
2026-08-28
Target enrollment:
Participant gender:
Summary
This is an open-label, randomized study evaluating the short-term glycemic effects of two concentrations of liquid metformin formulations (100 mg/mL and 250 mg/mL) compared with standard immediate-release metformin tablets in healthy adult subjects. Participants will receive single or short-term doses of study treatments in a randomized sequence. Blood glucose measurements and other glycemic indicators will be collected to assess short-term pharmacodynamic effects. Safety and tolerability will also be monitored.